18F-FP-CIT dopamine transporter PET findings in the striatum and retina of type 1 diabetic rats-Reference-Cited by-同舟云学术

18F-FP-CIT dopamine transporter PET findings in the striatum and retina of type 1 diabetic rats

Published:2023-01-06 Issue:4 Volume:37 Page:219-226
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Chen Ping,Li Jun,Li Zhan,Yu Duxia,Ma Ning,Xia Zian,Meng Xianglei,Liu Xingdang^ORCID

Funder

Key Technologies Research and Development Program

Science and Technology Planning Project of Shenzhen Municipality

Pudong New Area Clinical Characteristic Discipline Project

Pudong Hospital, Fudan University, College Level Project

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12149-022-01818-5.pdf

Reference47 articles.

1. Tian T, Li Z, Lu H. Common pathophysiology affecting diabetic retinopathy and Parkinson’s disease. Med Hypotheses. 2015;85(4):397–8.

2. Pérez-Taboada I, et al. Diabetes causes dysfunctional dopamine neurotransmission favoring nigrostriatal degeneration in mice. Mov Disord. 2020;35(9):1636–48.

3. Kono T, Takada M. Dopamine depletion in nigrostriatal neurons in the genetically diabetic rat. Brain Res. 1994;634(1):155–8.

4. Lahouaoui H, et al. Diabetic retinopathy alters light-induced clock gene expression and dopamine levels in the mouse retina. Mol Vis. 2016;22:959–69.

5. Moore-Dotson JM, et al. Early retinal neuronal dysfunction in diabetic mice: reduced light-evoked inhibition increases rod pathway signaling. Invest Ophthalmol Vis Sci. 2016;57(3):1418–30.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The wings of progress: technological and radiopharmaceutical innovations in nuclear medicine;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-12

2. Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes;Biomedicines;2023-11-07